Abstract
Genomic studies of patients with COVID-19, or exposed to it, are underway to delineate host factors associated with variability in susceptibility, infectivity, and disease severity. Here, we highlight the ethical implications-both potential benefits and harms-of genomics for clinical practice and public health in the era of COVID-19.
Keywords:
COVID-19; Ethics; Host genomics.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Betacoronavirus
-
COVID-19
-
Clinical Decision-Making / methods
-
Coronavirus Infections / pathology*
-
Coronavirus Infections / therapy
-
Genetic Predisposition to Disease / genetics*
-
Genetic Testing / ethics*
-
Genomics / ethics*
-
Genomics / methods
-
Humans
-
Pandemics
-
Pneumonia, Viral / pathology*
-
Pneumonia, Viral / therapy
-
Public Health / ethics*
-
Public Health / methods
-
SARS-CoV-2